Reversibility of Cardiac Conduction Disturbances Following TAVI

NARecruitingINTERVENTIONAL
Enrollment

209

Participants

Timeline

Start Date

June 17, 2024

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2026

Conditions
Aortic StenosisTranscatheter Aortic Valve ImplantationConduction Disturbances
Interventions
DIAGNOSTIC_TEST

Electrophysiological study (EP study)

Electrophysiological study: A second EP study 30-45 days after TAVI will be performed in the group of patients with positive EP study 3-7 days after TAVI.

DIAGNOSTIC_TEST

ePatch (extended Holter Monitoring)

Continuous cardiac rhythm monitoring using the ePatch (Philips) will be performed during 4 weeks after TAVI

Trial Locations (1)

08097

RECRUITING

Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat

All Listed Sponsors
collaborator

Hospital Universitari de Bellvitge

OTHER

collaborator

Hospital Universitario La Paz

OTHER

collaborator

Hospital Vall d'Hebron

OTHER

collaborator

Hospital Universitario Ramon y Cajal

OTHER

collaborator

Hospital Universitario A Coruna Spain

UNKNOWN

collaborator

Hospital Clinico Universitario de Santiago

OTHER

collaborator

Hospital Universitario Central de Asturias

OTHER

collaborator

Hospital Universitario Marqués de Valdecilla

OTHER

collaborator

Hospital Clínico Universitario de Valladolid

OTHER

lead

Institut d'Investigació Biomèdica de Bellvitge

OTHER